A single arm, investigative, phase II study of anti-PD-1 antibody SHR1210 in advanced pulmonary sarcomatoid carcinoma who failed to first line chemotherapy
Latest Information Update: 04 Aug 2020
At a glance
- Drugs Camrelizumab (Primary)
- Indications Lung cancer
- Focus Therapeutic Use
- 04 Aug 2020 New trial record